BioCritica
Indianapolis
About BioCritica
BioCritica is a biotechnology company focused on meeting the critical care needs of patients and clinicians in the hospital market. In addition to Xigris for the treatment of severe sepsis, BioCritica is developing a pipeline of other products. Their mission is to develop and commercialize products that make a dramatic improvement in people's lives.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Total funding: $25.0M
- Funding stage: Private Equity
- Last round: Private Equity (May 2011)
- Website: biocritica.com
- Phone: 317-575-4035
Industries & Categories
Biotechnology, Life Science, Therapeutics
Canonical: https://fsome.com/organization/biocritica-1455050 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.